Orris

What is the reason for micro orchardism in Noonan syndrome?

Reading File
Finding Sources
Searching PubMed

Noonan syndrome AND cryptorchidism

Searching the Web

Noonan syndrome cryptorchidism cause mechanism authoritative

Micro-orchidism (small testes) in Noonan syndrome is mainly related to testicular dysgenesis and cryptorchidism.
  • Noonan syndrome is a RAS-MAPK pathway disorder. This pathway is involved in normal fetal growth and gonadal development.
  • Many affected boys have undescended testes (cryptorchidism). A testis retained in the abdomen or inguinal canal is exposed to higher temperature, causing progressive loss of germ cells and impaired seminiferous-tubule development. This can result in testicular atrophy and small testes.
  • Some males also have primary testicular dysfunction, affecting Sertoli-cell and/or Leydig-cell function, which can contribute to reduced testicular volume, impaired spermatogenesis, and subfertility.
So, the usual exam answer is: micro-orchidism in Noonan syndrome is chiefly due to bilateral cryptorchidism with consequent testicular atrophy, often compounded by intrinsic gonadal dysgenesis.
Noonan syndrome is also associated with genitourinary abnormalities including cryptorchidism, as described in Thompson & Thompson Genetics and Genomics in Medicine (block 5, lines 3556-3561).

Does females have normal ovaries in Noonan syndrome?

Reading File
Finding Sources
Searching PubMed

Noonan syndrome AND ovarian function

Searching the Web

Noonan syndrome females ovarian function fertility GeneReviews

Yes. Most females with Noonan syndrome have structurally and functionally normal ovaries, and fertility is usually normal.
They may have delayed puberty or delayed menarche, but this does not usually reflect ovarian failure. This differs from Turner syndrome, where streak ovaries and primary ovarian insufficiency are common. GeneReviews states that normal fertility is the rule in females with Noonan syndrome.

See, you said Noonan syndrome is associated with RAS-MAPK pathway disorder, right? Which is helpful in growth and development of gonads. Why it isn't affecting in females?

Reading File
Finding Sources
Searching PubMed

Noonan syndrome AND gonadal function

Searching the Web

Noonan syndrome sex differences gonadal function female fertility cryptorchidism RAS MAPK review

That is a good question. The key point is: the RAS-MAPK pathway is important in both testes and ovaries, but Noonan syndrome does not switch the pathway off. Its gene variants usually cause dysregulated, often increased, signaling. The effect depends on the cell type, developmental stage, and specific Noonan-associated gene variant.
Why males are affected more often:
  1. Testicular descent is a male-specific vulnerable process.
    Cryptorchidism occurs in about 60% to 80% of males with Noonan syndrome. An undescended testis can lose germ cells because of its higher-temperature location, leading to smaller testes and impaired sperm production.
  2. There may be a direct testicular effect.
    RAS-MAPK signaling, including PTPN11/SHP2, has important roles in Sertoli-cell development and maintenance of spermatogonial stem cells. Studies find Sertoli-cell dysfunction even in some boys whose testes descended normally. This supports an intrinsic male gonadal effect, not only damage from cryptorchidism. GeneReviews and a 2023 systematic review describe this.
  3. Female ovarian function seems more resilient to the usual Noonan variants.
    RAS-MAPK signaling does participate in follicular maturation and ovulation, but the usual degree and pattern of signaling dysregulation in Noonan syndrome generally does not cause the marked follicle loss or gonadal dysgenesis seen in Turner syndrome. Thus, most females undergo puberty, have normal ovaries, and are fertile.
  4. “Usually normal” does not mean “never affected.”
    Girls with Noonan syndrome can have delayed puberty and later menarche. Evidence about subtle ovarian dysfunction is limited, so an individual with absent/delayed puberty, irregular cycles, or infertility should have an endocrine and gynecologic assessment.
So the concise comparison is:
  • Male: RAS-MAPK-related testicular developmental vulnerability + frequent cryptorchidism + Sertoli-cell dysfunction
  • Female: the pathway is involved, but typical Noonan variants usually preserve sufficient ovarian development and function
This sex difference is observed clinically, but the complete molecular explanation is still not fully established.
This is a shared conversation. Sign in to Orris to start your own chat.